As a potential tumor suppressor, DACH1 promoted hypermethylation and correspondingly reduced expression of DACH1 was observed in several kinds of cancers, including esophageal cancer, gastric cancer, colorectal cancer and hepatocellular carcinoma [20,22,31,32]. The gene discussed is DACH1; the disease is gastric cancer.